Anglum Gregory O - 11 Feb 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Reporting relationship: SVP & CFO
Issuer ticker: BVS
Reported as of: 11 Feb 2022
Net transaction value: -$15,518
SEC form: 4
Accepted by SEC: 15 Feb 2022, 20:27:43 UTC
Prior SEC filing: 14 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Anthony D'Adamio, Attorney-in-Fact

Key filing fact

Anglum Gregory O filed Form 4 for Bioventus Inc. (BVS) on 15 Feb 2022.

Key facts

This page summarizes Anglum Gregory O's Form 4 filing for Bioventus Inc. (BVS).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Feb 2022, 20:27.

Change

Previous filing in this sequence was filed on 14 Feb 2022.
Current net transaction value: -$15,518.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BVS transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +4,400
Change %: +8.5%
Price
Shares after: 56,307
Date: 11 Feb 2022
Ownership: Direct
Footnotes: F1

BVS transaction

Class A Common Stock

Sale

Transaction value: $15,518
Shares: -1,294
Change %: -2.3%
Price: $11.99
Shares after: 55,013
Date: 14 Feb 2022
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BVS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -4,400
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Feb 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 4,400
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Footnote F2

Reflects shares sold to cover taxes upon the vesting of restricted stock units on February 11, 2022 pursuant to a standing 10b5-1 instruction.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.99 to $12.105, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F4

The restricted stock units vested on February 11, 2022.